Tango Therapeutics, Inc. (TNGX) on GreekSoup https://greeksoup.ai/stocks/us/tngx/ Every dated entry in the public record on Tango Therapeutics, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 28 Oct 2026 00:00:00 +0000 Tango Therapeutics, Inc. filed 8-K: regulation fd disclosure, other eventshttps://greeksoup.ai/stocks/us/tngx/filings/us:TNGX:filing:2026-10-23:a98aff5997Fri, 23 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Tango Therapeutics, Inc.: short interest 44,777,592 shares at the 15 October 2026 settlement, 11.16 days to coverhttps://greeksoup.ai/stocks/us/tngx/short-interest/us:TNGX:short-interest:2026-10-15:549e8b4af9Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Tango Therapeutics, Inc.: Crystal Adam (President, R&D) sold 26,400 shares (under a trading plan set in advance) at $24.45 on 1 October 2026, $645,604https://greeksoup.ai/stocks/us/tngx/insiders/us:TNGX:insider:2026-10-05:69613ced41Mon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Tango Therapeutics, Inc.: Crystal Adam (President, R&D) sold 600 shares (under a trading plan set in advance) at $25.32 on 1 October 2026, $15,192https://greeksoup.ai/stocks/us/tngx/insiders/us:TNGX:insider:2026-10-05:5780c2f35eMon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Tango Therapeutics, Inc.: short interest 44,500,110 shares at the 30 September 2026 settlement, 12.54 days to coverhttps://greeksoup.ai/stocks/us/tngx/short-interest/us:TNGX:short-interest:2026-09-30:f3a616a6caWed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Tango Therapeutics, Inc.: Newcomb Jessica (Principal Accounting Officer) sold 700 shares (under a trading plan set in advance) at $22.80 on 22 September 2026, $15,962https://greeksoup.ai/stocks/us/tngx/insiders/us:TNGX:insider:2026-09-24:589b8b42a5Thu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Tango Therapeutics, Inc.: Newcomb Jessica (Principal Accounting Officer) sold 5,100 shares (under a trading plan set in advance) at $23.97 on 22 September 2026, $122,238https://greeksoup.ai/stocks/us/tngx/insiders/us:TNGX:insider:2026-09-24:d6ffe615cbThu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Tango Therapeutics, Inc.: Newcomb Jessica (Principal Accounting Officer) sold 2,400 shares (under a trading plan set in advance) at $25.17 on 22 September 2026, $60,412https://greeksoup.ai/stocks/us/tngx/insiders/us:TNGX:insider:2026-09-24:c0f7afe18cThu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Tango Therapeutics, Inc.: Form 144, Jessica Newcomb plans to sell 15,231 shares worth $340,108 around 22 September 2026https://greeksoup.ai/stocks/us/tngx/planned-sales/us:TNGX:planned-sale:2026-09-22:2f53fca2f3Tue, 22 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Tango Therapeutics, Inc.: short interest 41,872,812 shares at the 15 September 2026 settlement, 18.76 days to coverhttps://greeksoup.ai/stocks/us/tngx/short-interest/us:TNGX:short-interest:2026-09-15:83a49d0fffTue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Tango Therapeutics, Inc.: Crystal Adam (President, R&D) sold 27,000 shares (under a trading plan set in advance) at $22.37 on 1 September 2026, $603,909https://greeksoup.ai/stocks/us/tngx/insiders/us:TNGX:insider:2026-09-03:3b5559bb43Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Tango Therapeutics, Inc.: short interest 42,627,550 shares at the 31 August 2026 settlement, 19.70 days to coverhttps://greeksoup.ai/stocks/us/tngx/short-interest/us:TNGX:short-interest:2026-08-31:984c386939Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Tango Therapeutics, Inc.: Schedule 13G/A filed by Nextech Crossover I GP S.a. r.l., 0.0% of the classhttps://greeksoup.ai/stocks/us/tngx/holders/us:TNGX:schedule-13:2026-08-14:0071c14228Fri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Tango Therapeutics, Inc.: Schedule 13G/A filed by TCG Crossover GP II, LLC, 7.0% of the classhttps://greeksoup.ai/stocks/us/tngx/holders/us:TNGX:schedule-13:2026-08-14:c4cf0c8dcaFri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Tango Therapeutics, Inc.: Schedule 13G/A filed by Woodline Partners LP, 2.5% of the classhttps://greeksoup.ai/stocks/us/tngx/holders/us:TNGX:schedule-13:2026-08-14:fe2b5a60c3Fri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Tango Therapeutics, Inc.: Schedule 13G/A filed by Farallon Capital Management, L.L.C., 9.8% of the classhttps://greeksoup.ai/stocks/us/tngx/holders/us:TNGX:schedule-13:2026-08-14:47961c32cbFri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Tango Therapeutics, Inc.: Schedule 13G filed by THE GOLDMAN SACHS GROUP, INC., 6.0% of the classhttps://greeksoup.ai/stocks/us/tngx/holders/us:TNGX:schedule-13:2026-08-14:6bd4083017Fri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Tango Therapeutics, Inc.: short interest 43,186,169 shares at the 14 August 2026 settlement, 20.93 days to coverhttps://greeksoup.ai/stocks/us/tngx/short-interest/us:TNGX:short-interest:2026-08-14:64577d62a5Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Tango Therapeutics, Inc.: Schedule 13G/A filed by Adage Capital Management, L.P., 3.4% of the classhttps://greeksoup.ai/stocks/us/tngx/holders/us:TNGX:schedule-13:2026-08-12:c6bbc48f96Wed, 12 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Tango Therapeutics, Inc. Q2 FY2026 results: revenue $0, net income -$55 millionhttps://greeksoup.ai/stocks/us/tngx/results/fy2026-q2/us:TNGX:result:2026-08-11:7e70083665Tue, 11 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Tango Therapeutics, Inc. filed 8-K: other eventshttps://greeksoup.ai/stocks/us/tngx/filings/us:TNGX:filing:2026-08-11:e33a9321b6Tue, 11 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Tango Therapeutics, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/tngx/filings/us:TNGX:filing:2026-08-11:3d6cc01ca2Tue, 11 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Tango Therapeutics, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/tngx/filings/us:TNGX:filing:2026-08-11:072ef65a25Tue, 11 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Tango Therapeutics, Inc. filed 8-K/A: officer or director change, regulation fd disclosurehttps://greeksoup.ai/stocks/us/tngx/filings/us:TNGX:filing:2026-08-07:8cba313f32Fri, 07 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Tango Therapeutics, Inc. filed 8-K: officer or director changehttps://greeksoup.ai/stocks/us/tngx/filings/us:TNGX:filing:2026-08-06:826b4d31b0Thu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Tango Therapeutics, Inc.: Crystal Adam (President, R&D) sold 5,267 shares (under a trading plan set in advance) at $26.79 on 3 August 2026, $141,100https://greeksoup.ai/stocks/us/tngx/insiders/us:TNGX:insider:2026-08-05:fbaf415a2fWed, 05 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Tango Therapeutics, Inc.: Crystal Adam (President, R&D) sold 21,733 shares (under a trading plan set in advance) at $27.35 on 3 August 2026, $594,417https://greeksoup.ai/stocks/us/tngx/insiders/us:TNGX:insider:2026-08-05:fdc9ded053Wed, 05 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Tango Therapeutics, Inc.: Form 144, ADAM CRYSTAL plans to sell 81,000 shares worth $2.2 million around 3 August 2026https://greeksoup.ai/stocks/us/tngx/planned-sales/us:TNGX:planned-sale:2026-08-03:12b8f3b42fMon, 03 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Tango Therapeutics, Inc.: short interest 44,608,423 shares at the 31 July 2026 settlement, 19.15 days to coverhttps://greeksoup.ai/stocks/us/tngx/short-interest/us:TNGX:short-interest:2026-07-31:a003f281b6Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>